These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
11-2481903
|
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
1450 Broadway, New York, NY
|
10018
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
x
|
Accelerated filer
¨
|
|
Non - accelerated filer
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
¨
|
|
Page No.
|
||
|
Part I.
|
Financial Information
|
3
|
|
Item 1.
|
Financial Statements
|
3
|
|
Condensed Consolidated Balance Sheets – March 31, 2011 (unaudited) and December 31, 2010
|
3
|
|
|
Unaudited Condensed Consolidated Income Statements – Three Months Ended March 31, 2011 and 2010
|
4
|
|
|
Unaudited Condensed Consolidated Statement of Stockholders' Equity – Three Months Ended March 31, 2011
|
5
|
|
|
Unaudited Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2011 and 2010
|
6
|
|
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
8
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
22
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
27
|
|
Item 4.
|
Controls and Procedures
|
28
|
|
Part II.
|
Other Information
|
28
|
|
Item 1.
|
Legal Proceedings
|
28
|
|
Item 1A.
|
Risk Factors
|
28
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
33
|
|
Item 6.
|
Exhibits
|
33
|
|
Signatures
|
33
|
|
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(unaudited)
|
||||||||
|
Assets
|
||||||||
|
Current Assets:
|
||||||||
|
Cash (including restricted cash of $3,837 in 2011 and $3,300 in 2010)
|
$ | 99,895 | $ | 121,935 | ||||
|
Accounts receivable
|
71,821 | 65,507 | ||||||
|
Deferred income tax assets
|
1,743 | 1,743 | ||||||
|
Other assets - current
|
34,822 | 36,681 | ||||||
|
Total Current Assets
|
208,281 | 225,866 | ||||||
|
Property and equipment:
|
||||||||
|
Furniture, fixtures and equipment
|
16,707 | 14,894 | ||||||
|
Less: Accumulated depreciation
|
(4,995 | ) | (4,410 | ) | ||||
| 11,712 | 10,484 | |||||||
|
Other Assets:
|
||||||||
|
Restricted cash
|
15,866 | 15,866 | ||||||
|
Other assets
|
34,619 | 43,128 | ||||||
|
Trademarks and other intangibles, net
|
1,398,505 | 1,400,550 | ||||||
|
Deferred financing costs, net
|
2,706 | 3,119 | ||||||
|
Investments and joint ventures
|
58,501 | 59,677 | ||||||
|
Goodwill
|
192,780 | 192,780 | ||||||
| 1,702,977 | 1,715,120 | |||||||
|
Total Assets
|
$ | 1,922,970 | $ | 1,951,470 | ||||
|
Liabilities and Stockholders' Equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 38,067 | $ | 43,275 | ||||
|
Deferred revenue
|
23,609 | 16,305 | ||||||
|
Current portion of long-term debt
|
148,119 | 36,380 | ||||||
|
Other liabilities - current
|
5,300 | 4,000 | ||||||
|
Total current liabilities
|
215,095 | 99,960 | ||||||
|
Deferred income tax liability
|
144,254 | 138,577 | ||||||
|
Long-term debt, less current maturities
|
371,375 | 548,007 | ||||||
|
Deferred revenue
|
6,394 | 11,561 | ||||||
|
Other liabilities
|
12,756 | 14,451 | ||||||
|
Total Liabilities
|
749,874 | 812,556 | ||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders' Equity
|
||||||||
|
Common stock, $.001 par value shares authorized 150,000; shares issued 74,167 and 73,930, respectively
|
74 | 74 | ||||||
|
Additional paid-in capital
|
756,857 | 752,803 | ||||||
|
Retained earnings
|
325,748 | 294,316 | ||||||
|
Accumulated other comprehensive gain
|
253 | - | ||||||
|
Less: Treasury stock – 1,480 and 1,409 shares at cost, respectively
|
(12,651 | ) | (10,831 | ) | ||||
|
Total Iconix Stockholders’ Equity
|
1,070,281 | 1,036,362 | ||||||
|
Non-controlling interest
|
102,815 | 102,552 | ||||||
|
Total Stockholders’ Equity
|
1,173,096 | 1,138,914 | ||||||
|
Total Liabilities and Stockholders' Equity
|
$ | 1,922,970 | $ | 1,951,470 | ||||
|
Three Months Ended March
31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Licensing and other revenue
|
$ | 92,356 | $ | 71,704 | ||||
|
Selling, general and administrative expenses
|
32,005 | 22,318 | ||||||
|
Expenses related to specific litigation
|
47 | 6 | ||||||
|
Operating income
|
60,304 | 49,380 | ||||||
|
Other expenses
|
||||||||
|
Interest expense
|
9,936 | 11,029 | ||||||
|
Interest and other income
|
(601 | ) | (1,054 | ) | ||||
|
Equity earnings on joint ventures
|
(621 | ) | (1,113 | ) | ||||
|
Other expenses - net
|
8,714 | 8,862 | ||||||
|
Income before income taxes
|
51,590 | 40,518 | ||||||
|
Provision for income taxes
|
16,464 | 13,159 | ||||||
|
Net income
|
$ | 35,126 | $ | 27,359 | ||||
|
Less: Net income attributable to non-controlling interest
|
$ | 3,694 | $ | 2,585 | ||||
|
Net income attributable to Iconix Brand Group, Inc.
|
$ | 31,432 | $ | 24,774 | ||||
|
Earnings per share:
|
||||||||
|
Basic
|
$ | 0.43 | $ | 0.35 | ||||
|
Diluted
|
$ | 0.42 | $ | 0.33 | ||||
|
Weighted average number of common shares outstanding:
|
||||||||
|
Basic
|
72,768 | 71,537 | ||||||
|
Diluted
|
75,370 | 74,426 | ||||||
|
Accumulated
|
||||||||||||||||||||||||||||||||
|
Additional
|
Other
|
Non-
|
||||||||||||||||||||||||||||||
|
Common Stock
|
Paid-in
|
Retained
|
Comprehensive
|
Treasury
|
Controlling
|
|||||||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Earnings
|
Gain
|
Stock
|
Interest
|
Total
|
|||||||||||||||||||||||||
|
Balance at January 1, 2011
|
73,930 | $ | 74 | $ | 752,803 | $ | 294,316 | $ | - | $ | (10,831 | ) | $ | 102,552 | $ | 1,138,914 | ||||||||||||||||
|
Shares issued on exercise of stock options
|
163 | - | 1,025 | - | - | - | - | 1,025 | ||||||||||||||||||||||||
|
Shares issued on vesting of restricted stock
|
74 | - | - | - | - | - | - | - | ||||||||||||||||||||||||
|
Tax benefit of stock option exercises
|
- | - | 735 | - | - | - | 735 | |||||||||||||||||||||||||
|
Compensation expense in connection with restricted stock and stock options
|
- | - | 2,294 | - | - | - | - | 2,294 | ||||||||||||||||||||||||
|
Shares repurchased on vesting of restricted stock and exercise of stock options
|
- | - | - | - | - | (1,820 | ) | - | (1,820 | ) | ||||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||||||||||
|
Net income
|
- | - | - | 31,432 | - | - | 3,694 | 35,126 | ||||||||||||||||||||||||
|
Change in fair value of hedges
|
- | - | - | - | 253 | - | - | 253 | ||||||||||||||||||||||||
|
Total comprehensive income
|
- | - | - | - | - | - | - | 35,379 | ||||||||||||||||||||||||
|
Distributions to joint ventures
|
- | - | - | - | - | - | (3,431 | ) | (3,431 | ) | ||||||||||||||||||||||
|
Balance at March 31, 2011
|
74,167 | $ | 74 | $ | 756,857 | $ | 325,748 | $ | 253 | $ | (12,651 | ) | $ | 102,815 | $ | 1,173,096 | ||||||||||||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 35,126 | $ | 27,359 | ||||
|
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
|
||||||||
|
Depreciation of property and equipment
|
585 | 320 | ||||||
|
Amortization of trademarks and other intangibles
|
2,074 | 2,106 | ||||||
|
Amortization of deferred financing costs
|
561 | 573 | ||||||
|
Amortization of convertible note discount
|
3,843 | 3,670 | ||||||
|
Stock-based compensation expense
|
2,294 | 2,228 | ||||||
|
Provision for doubtful accounts
|
495 | 1,750 | ||||||
|
Equity earnings on joint ventures
|
(621 | ) | (1,113 | ) | ||||
|
Deferred income tax provision
|
5,677 | 3,663 | ||||||
|
Changes in operating assets and liabilities, net of business acquisitions:
|
||||||||
|
Accounts receivable
|
(6,809 | ) | (112 | ) | ||||
|
Other assets - current
|
2,912 | (1,974 | ) | |||||
|
Other assets
|
10,909 | 849 | ||||||
|
Deferred revenue
|
2,137 | 1,269 | ||||||
|
Accounts payable and accrued expenses
|
(5,207 | ) | 11,288 | |||||
|
Other liabilities
|
405 | 23 | ||||||
|
Net cash provided by operating activities
|
54,381 | 51,899 | ||||||
|
Cash flows (used in) provided by investing activities:
|
||||||||
|
Purchases of property and equipment
|
(1,813 | ) | (24 | ) | ||||
|
Acquisition of interest in MG Icon
|
- | (4,000 | ) | |||||
|
Payment of accrued expenses related to acquisitions
|
- | (173 | ) | |||||
|
Net distributions (to) from equity partners
|
(1,634 | ) | 999 | |||||
|
Earn-out payment on acquisition
|
- | (719 | ) | |||||
|
Additions to trademarks
|
(29 | ) | (9 | ) | ||||
|
Net cash used in investing activities
|
(3,476 | ) | (3,926 | ) | ||||
|
Cash flows (used in) provided by financing activities:
|
||||||||
|
Proceeds from exercise of stock options and warrants
|
1,025 | 515 | ||||||
|
Payment of long-term debt
|
(68,885 | ) | (55,564 | ) | ||||
|
Acquisition of interest in MG Icon
|
(4,000 | ) | - | |||||
|
Excess tax benefit from share-based payment arrangements
|
735 | 27 | ||||||
|
Shares repurchased on vesting of restricted stock
|
(1,820 | ) | - | |||||
|
Restricted cash - current
|
(537 | ) | (2,373 | ) | ||||
|
Net cash used in financing activities
|
(73,482 | ) | (57,395 | ) | ||||
|
Net decrease in cash and cash equivalents
|
(22,577 | ) | (9,422 | ) | ||||
|
Cash and cash equivalents, beginning of period
|
118,635 | 195,381 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 96,058 | $ | 185,959 | ||||
|
Balance of restricted cash - current
|
3,837 | 8,536 | ||||||
|
Total cash and cash equivalents including current restricted cash, end of year
|
$ | 99,895 | $ | 194,495 | ||||
|
Three Months Ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cash paid during the period:
|
||||||||
|
Income taxes
|
$ | 4,502 | $ | - | ||||
|
Interest
|
$ | 4,547 | $ | 4,131 | ||||
|
Three Months Ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Acquisitions:
|
||||||||
|
Common stock issued
|
$ | - | $ | 4,719 | ||||
|
March 31, 2011
|
December 31, 2010
|
||||||||||||||||||
|
Estimated
|
Gross
|
Gross
|
|||||||||||||||||
|
Lives in
|
Carrying
|
Accumulated
|
Carrying
|
Accumulated
|
|||||||||||||||
|
(000's omitted)
|
Years
|
Amount
|
Amortization
|
Amount
|
Amortization
|
||||||||||||||
|
Indefinite life trademarks and copyrights
|
Indefinite
|
$ | 1,373,306 | $ | - | $ | 1,382,775 | $ | 9,498 | ||||||||||
|
Definite life trademarks
|
10-15 | 19,579 | 5,533 | 19,579 | 5,169 | ||||||||||||||
|
Non-compete agreements
|
2-15 | 10,475 | 9,432 | 10,475 | 9,092 | ||||||||||||||
|
Licensing agreements
|
1-9 | 30,103 | 19,993 | 30,103 | 18,640 | ||||||||||||||
|
Domain names
|
5 | 570 | 570 | 570 | 553 | ||||||||||||||
| $ | 1,434,033 | $ | 35,528 | $ | 1,443,502 | $ | 42,952 | ||||||||||||
|
Carrying Amount as of
|
|||||||||||||
|
March 31, 2011
|
Valuation
|
||||||||||||
|
(
000's omitted
)
|
Level 1
|
Level 2
|
Level 3
|
Technique
|
|||||||||
|
Marketable Securities
|
$
|
-
|
$
|
-
|
$
|
-
|
(A)
|
||||||
|
Income Statement Hedge
|
$
|
-
|
$
|
253
|
$
|
-
|
(A)
|
||||||
|
Balance Sheet Hedge
|
$
|
$
|
-
|
$
|
-
|
(A)
|
|||||||
|
Carrying Amount as of
|
|||||||||||||
|
December 31, 2010
|
Valuation
|
||||||||||||
|
(
000's omitted
)
|
Level 1
|
Level 2
|
Level 3
|
Technique
|
|||||||||
|
Marketable Securities
|
$
|
-
|
$
|
-
|
$
|
-
|
(A)
|
||||||
|
Auction Rate Securities
(000's omitted)
|
||||||||
|
Three Months Ended March
31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Balance at beginning of period
|
$
|
-
|
$
|
6,988
|
||||
|
Additions
|
-
|
-
|
||||||
|
Gains (losses) reported in earnings
|
-
|
-
|
||||||
|
Gains (losses) reported in accumulated other comprehensive loss
|
-
|
296
|
||||||
|
Balance at end of period
|
$
|
-
|
$
|
7,284
|
||||
|
(000's omitted)
|
March 31, 2011
|
December 31, 2010
|
||||||||||||||
|
Carrying Amount
|
Fair Value
|
Carrying Amount
|
Fair Value
|
|||||||||||||
|
Long-term debt, including current portion
|
$
|
519,494
|
$
|
548,606
|
$
|
584,387
|
$
|
607,592
|
||||||||
|
March 31,
|
December 31,
|
|||||||
|
(000’s omitted)
|
2011
|
2010
|
||||||
|
Convertible Notes
|
$ | 266,560 | $ | 262,716 | ||||
|
Term Loan Facility
|
111,169 | 171,021 | ||||||
|
Ecko Note
|
77,500 | 80,000 | ||||||
|
Asset-Backed Notes
|
64,265 | 70,650 | ||||||
|
Total
|
$ | 519,494 | $ | 584,387 | ||||
|
March 31,
|
December 31,
|
|||||||
|
(000’s omitted)
|
2011
|
2010
|
||||||
|
Equity component carrying amount
|
$ | 41,309 | $ | 41,309 | ||||
|
Unamortized discount
|
20,940 | 24,784 | ||||||
|
Net debt carrying amount
|
266,560 | 262,716 | ||||||
|
(000’s omitted)
|
Total
|
April 1
through
December 31,
2011
|
2012
|
2013
|
2014
|
2015
|
||||||||||||||||||
|
Convertible Notes (1)
|
$ | 266,560 | $ | - | $ | 266,560 | $ | - | $ | - | $ | - | ||||||||||||
|
Term Loan Facility
|
111,169 | - | 111,169 | - | - | - | ||||||||||||||||||
|
Ecko Note
|
77,500 | 7,500 | 10,000 | 10,000 | 50,000 | - | ||||||||||||||||||
|
Asset-Backed Notes
|
64,265 | 19,996 | 33,468 | 10,801 | - | - | ||||||||||||||||||
|
Total
|
$ | 519,494 | $ | 27,496 | $ | 421,197 | $ | 20,801 | $ | 50,000 | $ | - | ||||||||||||
|
Expected Volatility
|
30 - 50 | % | ||
|
Expected Dividend Yield
|
0 | % | ||
|
Expected Life (Term)
|
3 - 7 years
|
|||
|
Risk-Free Interest Rate
|
3.00 - 4.75 | % | ||
|
Options
|
Weighted-Average
|
|||||||
|
Options
|
Exercise Price
|
|||||||
|
Outstanding January 1, 2011
|
2,592,535 | $ | 4.61 | |||||
|
Granted
|
- | - | ||||||
|
Canceled
|
- | - | ||||||
|
Exercised
|
(163,385 | ) | 6.28 | |||||
|
Expired
|
- | - | ||||||
|
Outstanding March 31, 2011
|
2,429,150 | $ | 4.98 | |||||
|
Exercisable at March 31, 2011
|
2,427,483 | $ | 4.98 | |||||
|
Weighted-Average
|
||||||||
|
Warrants
|
Exercise Price
|
|||||||
|
Outstanding January 1, 2011
|
253,900 | $ | 17.01 | |||||
|
Granted
|
- | - | ||||||
|
Canceled
|
- | - | ||||||
|
Exercised
|
- | - | ||||||
|
Expired/Forfeited
|
- | - | ||||||
|
Outstanding March 31, 2011
|
253,900 | $ | 17.01 | |||||
|
Exercisable at March 31, 2011
|
253,900 | $ | 17.01 | |||||
|
Weighted-Average
|
||||||||
|
Shares
|
Grant Date Fair Value
|
|||||||
|
Non-vested, January 1, 2011
|
1,442,610
|
$
|
15.34
|
|||||
|
Granted
|
40,843
|
20.51
|
||||||
|
Vested
|
(26,956
|
)
|
21.30
|
|||||
|
Forfeited/Canceled
|
-
|
-
|
||||||
|
Non-vested, March 31, 2011
|
1,456,497
|
$
|
15.37
|
|||||
|
For the Three Months Ended
|
|||||||
|
(000's omitted)
|
March 31,
|
||||||
|
2011
|
2010
|
||||||
|
Basic
|
72,768
|
71,537
|
|||||
|
Effect of exercise of stock options and warrants
|
1,272
|
1,940
|
|||||
|
Effect of contingent common stock issuance
|
144
|
353
|
|||||
|
Effect of assumed vesting of restricted stock
|
1,186
|
596
|
|||||
|
Diluted
|
75,370
|
74,426
|
|||||
|
For the Three Months Ended
|
||||||||
|
(000's omitted)
|
March 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
Licensing and other revenue by category:
|
||||||||
|
Direct-to-retail license
|
$
|
42,617
|
$
|
38,564
|
||||
|
Wholesale license
|
45,096
|
32,602
|
||||||
|
Entertainment and other
|
4,643
|
538
|
||||||
|
$
|
92,356
|
$
|
71,704
|
|||||
|
Licensing and other revenue by geographic region:
|
||||||||
|
United States
|
$
|
75,910
|
$
|
68,173
|
||||
|
Other
|
16,446
|
3,531
|
||||||
|
$
|
92,356
|
$
|
71,704
|
|||||
|
|
•
|
could impair our liquidity;
|
|
|
•
|
could make it more difficult for us to satisfy our other obligations;
|
|
|
•
|
require us to dedicate a substantial portion of our cash flow to payments on our debt obligations, which reduces the availability of our cash flow to fund working capital, capital expenditures and other corporate requirements;
|
|
|
•
|
could impede us from obtaining additional financing in the future for working capital, capital expenditures, acquisitions and general corporate purposes;
|
|
|
•
|
impose restrictions on us with respect to the use of our available cash, including in connection with future acquisitions;
|
|
|
•
|
make us more vulnerable in the event of a downturn in our business prospects and could limit our flexibility to plan for, or react to, changes in our licensing markets; and
|
|
|
•
|
could place us at a competitive disadvantage when compared to our competitors who have less debt.
|
|
|
•
|
unanticipated costs associated with the target acquisition;
|
|
|
•
|
negative effects on reported results of operations from acquisition related charges and amortization of acquired intangibles;
|
|
|
•
|
diversion of management’s attention from other business concerns;
|
|
|
•
|
the challenges of maintaining focus on, and continuing to execute, core strategies and business plans as our brand and license portfolio grows and becomes more diversified;
|
|
|
•
|
adverse effects on existing licensing and joint venture relationships;
|
|
|
•
|
potential difficulties associated with the retention of key employees, and the assimilation of any other employees, who may be retained by us in connection with or as a result of our acquisitions; and
|
|
|
•
|
risks of entering new domestic and international markets (whether it be with respect to new licensed product categories or new licensed product distribution channels) or markets in which we have limited prior experience.
|
|
Month of purchase
|
Total number
of shares
purchased
|
Average
price
paid per share
|
Total number
of
shares
purchased as
publicly
announced
plans or
programs
(1)
|
Maximum
number
(or approximate
dollar
value) of
shares
that may yet
be
purchased
under the
plans or
programs
|
||||||||||||
|
January 1 – January 31
|
-
|
$
|
-
|
$
|
-
|
$
|
71,722,003
|
|||||||||
|
February 1 – February 28
|
59,640
|
$
|
22.73
|
$
|
-
|
$
|
71,722,003
|
|||||||||
|
March 1 – March 31
|
11,504
|
$
|
21.30
|
$
|
-
|
$
|
71,722,003
|
|||||||||
|
Total
|
71,144
|
$
|
22.50
|
$
|
-
|
$
|
71,722,003
|
|||||||||
|
|
(1)
|
On November 3, 2008, the Company announced that the Board of Directors authorized the repurchase of up to $75 million of the Company's common stock over a period ending October 30, 2011, herein referred to as the repurchase plan. This authorization replaces any prior plan or authorization. The repurchase plan does not obligate the Company to repurchase any specific number of shares and may be suspended at any time at management's discretion. Amounts not purchased under the repurchase plan represent shares surrendered to the Company to pay withholding taxes due upon the vesting of restricted stock.
|
|
EXHIBIT NO.
|
DESCRIPTION OF EXHIBIT
|
|
|
Exhibit 31.1
|
Certification of Chief Executive Officer Pursuant To Rule 13a-14 or 15d-14 of The Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002
|
|
|
Exhibit 31.2
|
Certification of Chief Financial Officer Pursuant To Rule 13a-14 or 15d-14 of The Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act of 2002
|
|
|
Exhibit 32.1
|
Certification of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of The Sarbanes-Oxley Act of 2002
|
|
|
Exhibit 32.2
|
Certification of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of The Sarbanes-Oxley Act of 2002
|
|
Iconix Brand Group, Inc.
(Registrant)
|
|
|
Date: May 5, 2011
|
/s/ Neil Cole
|
|
Neil Cole
Chairman of the Board, President
and Chief Executive Officer
(on Behalf of the Registrant)
|
|
Date: May 5, 2011
|
/s/ Warren Clamen
|
|
Warren Clamen
Executive Vice President
and Chief Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|